stock rating
Craig-Hallum Initiates Coverage of Personalis With Buy Rating
Craig-Hallum sees substantial growth opportunity in Personalis' pharma partnerships and focus on underpenetrated cancer markets.
Craig-Hallum Initiates Coverage of Myriad Genetics With a Buy Rating
Craig-Hallum expects stable Prolaris revenues and sees opportunities for significant growth in the hereditary cancer and prenatal testing markets.
Evercore ISI Upgrades Labcorp to Outperform
The bank upgraded Labcorp's stock on expectations of solid lab volume growth, accretive revenues from Labcorp's Invitae business, and margin expansion in 2025.
Jefferies Initiates Coverage of NeoGenomics, Hologic, QuidelOrtho
The investment bank said it prefers diagnostics companies with strong commercial engines, although noted it that Hologic and QuidelOrtho are in transition.
Wolfe Research Upgrades Danaher to Outperform
The upgrade is based on the firm's improving growth, more reasonable valuations, and its ability to deploy capital.
Oct 16, 2024
UBS Initiates Coverage of Veracyte With Buy Rating
Oct 15, 2024
Barclays Upgrades Revvity to Overweight
Feb 9, 2024
Evercore ISI Initiates Coverage of Labcorp
Dec 22, 2023
Wells Fargo Initiates Coverage of Revvity
Jul 31, 2023
Evercore, Barclays Downgrade Agilent Shares
Dec 6, 2022
Cowen Upgrades PerkinElmer Stock to Outperform
Jul 6, 2021